Abstract:
According to the complexity of human physiology and variability among individuals, e.g., genes, environment, lifestyle exposures, etc., personalized medicine aims to synt...Show MoreMetadata
Abstract:
According to the complexity of human physiology and variability among individuals, e.g., genes, environment, lifestyle exposures, etc., personalized medicine aims to synthesize the specific efficacious drug for each individual patient. For synthesizing personalized medicine, customized solutions with specific concentrations are required. Equipped with the advantages in saving costly reagents and rare samples, microfluidic biochips are promising in generating different concentrations for personalized medicine. On the one hand, digital microfluidic biochips require the programming control for driving the movement of the droplets, which suffer from random errors caused by imbalanced droplet splitting. On the other hand, existing flow-based microfluidic biochips can only generate linear concentration gradients, which cause significant waste for synthesizing personalized medicine. To address the above issues, this article proposes the first artificial neural network (ANN)-based design method for flow-based microfluidic biochips, which accurately generates the customized concentration gradients. According to the required concentration, an initial chip is first selected from the prebuilt database and then fine-tuned by ANN to better match the required concentration. The computational simulation results show that the induced deviations in generated concentrations are generally less than 0.014, which validates the accuracy of the proposed neural network model.
Published in: IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems ( Volume: 39, Issue: 10, October 2020)